Literature DB >> 10333644

[Aberrant expression of the GIP (Gastric Inhibitory Polypeptide) receptor in an adrenal cortical adenoma responsible for a case of food-dependent Cushing's syndrome].

J P Luton1, J Bertherat, J M Kuhn, X Bertagna.   

Abstract

A 33 year old woman was investigated for an atypical case of Cushing's syndrome with suppressed early morning plasma cortisols. Chronic hypercortisolism was confirmed by classical biological criteria (24 h urinary cortisol excretion, dexamethasone suppression tests); more detailed dynamic and pharmacological tests revealed unanticipated features: spontaneous circadian plasma cortisol variations showed post prandial peaks; they could be induced by oral--but not intravenous--glucose tolerance tests, and were inhibited by the concomitant administration of Sandostatin (a somatostatin analog). Adrenal CT scan identified a 2 cm unilateral adenoma with ipsilateral and contralateral atrophy. Surgical removal of the tumor cured the hypercortisolism with hypocortisolism. Comparative analysis of the tumoral and normal tissues showed that only the former responded in vitro to GIP (Gastric Inhibitory Polypeptide) and contained the specific mRNA of the GIP receptor. This case illustrates a new pathophysiological mechanism of tumorigenesis due to the aberrant expression of a seven transmembrane domain receptor in a tumoral tissue. The nature of the given receptor induced a particular clinical phenotype related to food intake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10333644

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN: 0001-4079            Impact factor:   0.144


  2 in total

Review 1.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

2.  Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Authors:  Anne-Lise Lecoq; Constantine A Stratakis; Say Viengchareun; Ronan Chaligné; Lucie Tosca; Vianney Deméocq; Mirella Hage; Annabel Berthon; Fabio R Faucz; Patrick Hanna; Hadrien-Gaël Boyer; Nicolas Servant; Sylvie Salenave; Gérard Tachdjian; Clovis Adam; Vanessa Benhamo; Eric Clauser; Anne Guiochon-Mantel; Jacques Young; Marc Lombès; Isabelle Bourdeau; Dominique Maiter; Antoine Tabarin; Jérôme Bertherat; Hervé Lefebvre; Wouter de Herder; Estelle Louiset; André Lacroix; Philippe Chanson; Jérôme Bouligand; Peter Kamenický
Journal:  JCI Insight       Date:  2017-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.